Evolving indications for permanent pacemakers

Annals of Internal Medicine

Volumn 134, Issue 12, 2001, Pages 1130-1141

  Bryce, M ^a   Spielman, S R ^a   Greenspan, A M ^a   Kotler, M N ^a  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTIFICIAL HEART PACEMAKER; CLINICAL OBSERVATION; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART DILATATION; HEART FAILURE; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART PACING; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MORTALITY; PRIORITY JOURNAL; REVIEW; SYMPTOM; SYNCOPE; TREATMENT INDICATION;

EID: 0035912743     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-134-12-200106190-00014     Document Type: Review

References (64)

1. Resuscitation of the heart in ventricular standstill by external electric stimulation
2. A transistorized self-contained, implantable pacemaker for the long-term correction of heart block
3. Therapeutic control of a threatening stage of idiopathic hypertrophic subaortic stenosis
4. Le traitement de la myocardiopathie obstructive par stimulation cardiaque
5. Results of electrical pacing in patients with hypertrophic obstruction cardiomyopathy
6. Atrial synchronous ventricular stimulation with reduced a.v. delay time as a therapeutic principle in hypertrophic obstructive cardiomyopathy
7. Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy
8. Influence of right ventricular pacing site on left ventricular outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy
9. Atrial systole and left ventricular filling in hypertrophic cardiomyopathy: Effect of verapamil
10. Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy
11. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy
12. Long-term effects of dual chamber pacing in patients with hypertrophic cardiomyopathy without outflow tract obstruction at rest
13. Dual-chamber pacing for hypertrophic cardiomyopathy: A randomized, double-blind, crossover trial
14. Pacing in hypertrophic obstructive cardiomyopathy. A randomized cross-over study
15. Effect of dual-chamber pacing on systolic and diastolic function in patients with hypertrophic cardiomyopathy. Acute Doppler echocardiographic and catheterization hemodynamic study
16. Significant improvement of quality of life following atrioventricular synchronous pacing in patients with hypertrophic obstructive cardiomyopathy. Data from 1 year of follow-up
17. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY)
18. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation
19. Functional abnormalities in isolated left bundle branch block. The effect of interventricular asynchrony
20. Effects of abnormal activation on the time course of the left ventricular pressure pulse in dilated cardiomyopathy
21. Effect of left bundle branch block on diastolic function in dilated cardiomyopathy
22. Interventricular conduction delays: A predictor of mortality in chronic heart failure?
23. Usefulness of physiologic dual-chamber pacing in drug-resistant idiopathic dilated cardiomyopathy
24. Long-term efficacy of physiologic dual-chamber pacing in the treatment of end-stage idiopathic dilated cardiomyopathy
25. Results of atrioventricular synchronous pacing with optimized delay in patients with severe congestive heart failure
26. Dual-chamber pacing with a short atrioventricular delay in congestive heart failure: A randomized study
27. Mechanism of hemodynamic improvement by dual-chamber pacing for severe left ventricular dysfunction: An acute Doppler and catheterization hemodynamic study
28. Biventricular stimulation: A more physiologic pacing
29. Beneficial effects of biventricular pacing in congestive heart failure
30. Biventricular pacing improves functional capacity in patients with end stage congestive heart failure
31. Long-term results of permanent biventricular pacing in refractory heart failure: Comparison between class III and class IV patients
32. The Pacing Therapies for Congestive Heart Failure (PATH-CHF) study: Rationale, design, and endpoints of a prospective randomized multicenter study
33. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure
34. Multisite pacing as a supplemental treatment of congestive heart failure: Preliminary results of the Medtronic Inc. In Sync Study
35. The MIRACLE Study: The In Sync Clinical Trial Program. Cardiac resynchronization for heart failure. The role of biventricular pacing
36. Biventricular pacing in patients with congestive heart failure: Two prospective randomized trials
37. Role of pacing in the treatment of vasovagal syncope
38. Guidelines for implantation of cardiac pacemakers and antiarrhythmia devices. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Pacemaker Implantation)
39. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: Executive summary - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation)
40. Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: A double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International Study
41. The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope
42. Follow-up of asystolic episodes in patients with cardioinhibitory, neurally mediated syncope and VVI pacemaker
43. Dual chamber pacing aborts vasovagal syncope induced by head-up 60 degrees tilt
44. Comparison of single and dual-chamber pacing techniques in prevention of upright tilt induced vasovagal syncope
45. Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole
46. Cardiac pacing does not improve orthostatic tolerance in patients with vasovagal syncope
47. Permanent pacing for cardioinhibitory malignant vasovagal syndrome
48. Clinical experience with Thera DR rate-drop response pacing algorithm in carotid sinus syndrome and vasovagal syncope
49. Effect of dual-chamber pacing with automatic rate-drop sensing on recurrent neurally mediated syncope
50. DDD pacing with rate drop response function versus DDI with rate hysteresis pacing for cardioinhibitory vasovagal syncope
51. The economics of treating vasovagal syncope
52. Multisite or alternate site pacing for the prevention of atrial fibrillation
53. Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome
54. Systematic trial of pacing to prevent atrial fibrillation (STOP-AF)
55. Biatrial synchronous pacing: A new approach to prevent arrhythmias in patients with atrial conduction block
56. Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing
57. Multicenter experience with single site and dual site atrial pacing in refractory atrial fibrillation
58. Left heart function during right heart pacing
59. Effects of different atrial pacing modes on atrial electrophysiology: Implicating the mechanism of biatrial pacing in prevention of atrial fibrillation
60. Regional atrial conduction delay for short coupled premature beats during single and dual site atrial pacing
61. Dual site atrial pacing promotes sinus rhythm in paroxysmal atrial fibrillation
62. Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single- and dual-site right atrial pacing for arrhythmia prevention
63. Evaluation of biatrial pacing, right atrial pacing, and no pacing in patients with drug refractory atrial fibrillation
64. Interatrial septum pacing: A new approach to prevent recurrent atrial fibrillation